What does total current liabilities mean?

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Polaryx Therapeutics, Inc. PLYX Total Current Liabilities

BioMarin PharmaceuticalsBMRN

$793.15M+26.3%

Zevra Therapeutics, Inc.ZVRA

$47.03M+74.3%

Eton Pharmaceuticals, Inc.ETON

$44.18M+74.3%

XER

Xeris Biopharma Holdings, Inc.XERS

$118.59M+24.7%

Relay Therapeutics, Inc.RLAY

$29.75M-19.7%

PVL

Palvella TherapeuticsPVLA

$9.12M+1.5%

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Operating cash flow-$2.1M-191%

Market cap$132.59M-87.6%

Return on equity-1,209.8%—

Current ratio3.5×—

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Polaryx Therapeutics, Inc. 's total current liabilities?: Polaryx Therapeutics, Inc. (PLYX) reported total current liabilities of $1.01M in Q1 2026.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.